Aldeyra Therapeutics, Inc. (ALDX)
Company Info
| ISIN | US01438T1060 |
|---|---|
| CUSIP | 01438T106 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $3.51B |
|---|---|
| EPS | $4.31 |
| PE Ratio | 14.17 |
| PEG Ratio | 2.31 |
| Revenue (TTM) | $1.90B |
| Gross Profit (TTM) | $446.80M |
| EBITDA (TTM) | $430.00M |
| Year Range | $48.67 - $64.36 |
| Target Price | $58.17 |
| Short % | 2.27% |
| Short Ratio | 3.14 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Aldeyra Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ALDX vs. SCHD
Return
Aldeyra Therapeutics, Inc. had a return of -54.74% year-to-date (YTD) and -49.19% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -54.74% | 18.49% |
| 1 month | 40.00% | 4.20% |
| 6 months | -72.56% | 6.60% |
| 1 year | -49.19% | 15.43% |
| 5 years (annualized) | -19.39% | 11.59% |
| 10 years (annualized) | N/A | 9.70% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -0.42% | -11.59% | -3.28% | -8.07% | -10.46% | -74.40% | 61.99% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Aldeyra Therapeutics, Inc. (ALDX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ALDX Aldeyra Therapeutics, Inc. | -0.46 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Aldeyra Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aldeyra Therapeutics, Inc. was 90.10%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.1% | Apr 28, 2021 | 631 | Oct 27, 2023 | — | — | — |
| -88.71% | Sep 28, 2018 | 367 | Mar 16, 2020 | 232 | Feb 16, 2021 | 599 |
| -70.91% | Feb 2, 2015 | 267 | Feb 24, 2016 | 652 | Sep 26, 2018 | 919 |
| -56.32% | Jun 20, 2014 | 31 | Aug 5, 2014 | 54 | Oct 21, 2014 | 85 |
| -31.86% | Oct 30, 2014 | 39 | Dec 26, 2014 | 14 | Jan 16, 2015 | 53 |
Volatility Chart
The current Aldeyra Therapeutics, Inc. volatility is 29.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.